Proxy Materials

Protagenic Therapeutics, Inc.new Filed 2025-05-19 Acc 0001641172-25-011502

Documents 1

2025-05-21 8-K Regulation FD disclosure
2025-05-20 8-K Material agreement · Unregistered share sale
2025-05-19 DEFA14A Proxy Materials
2025-05-19 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure · Other events
2025-05-13 10-Q Quarterly Report
2025-01-06 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading formdefa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…